Outcomes of transoral incisionless fundoplication (TIF 2.0): a prospective multicenter cohort study in academic and community gastroenterology and surgery practices (with video)
TIF 2.0 is a safe and effective endoscopic outpatient treatment option for selected patients with GERD.
Authors
- Barham Abu Dayyeh
- Harshit S. Khara (ORCID: https://orcid.org/0000-0003-2850-625X)
- Marcia Irene Canto (ORCID: https://orcid.org/0000-0002-2193-3032)
- Olaya I. Brewer Gutierrez (ORCID: https://orcid.org/0000-0001-6338-3801)
- Peter Janu (ORCID: https://orcid.org/0000-0001-7356-7399)
- Jennifer M. Kolb (ORCID: https://orcid.org/0000-0002-6352-0797)
- Brett Colton Parker (ORCID: https://orcid.org/0000-0002-0250-0581)
- Reem Z. Sharaiha (ORCID: https://orcid.org/0000-0002-3235-6904)
- Amit Sohagia
- David L. Diehl (ORCID: https://orcid.org/0000-0003-4128-3839)
- Michael J. Murray (ORCID: https://orcid.org/0000-0002-5407-4633)
- Kenneth Chang (ORCID: https://orcid.org/0000-0001-5722-031X)
Institutions
- Geisinger Medical Center (US)
- Mayo Clinic (US)
- NewYork–Presbyterian Hospital (US)
- Johns Hopkins University (US)
- Sierra Nevada Corporation (United States) (US)
- University of California, Irvine (US)
- Cornell University (US)
- WinnMed (US)
- Fox Valley Surgical Associates (US)
- NevadaNano (United States) (US)
- Institut de Recherche en Santé Digestive (FR)
- Sibley Memorial Hospital (US)
- Geisinger Commonwealth School of Medicine (US)
Publication Details
- Journal
- Gastrointestinal Endoscopy
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1016/j.gie.2024.08.016
- Citations
- 13
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.03